As the number of patients with each tumor type is limited, the correlation between some biomarkers (e.g. PD-1+ 4-1BB+ CD8 T cells and TMB in MM) and the lack of correlation between others (e.g. PD-L1 and TMB) should be considered exploratory requiring validation in larger cohorts. The gene discussed is CD8A; the disease is neoplasm.